S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)
S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)
S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)
S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)
NASDAQ:KERN

Akerna (KERN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
$0.31
$9.80
52-Week Range
N/A
Volume
1.42 million shs
Average Volume
339,022 shs
Market Capitalization
$3.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00

Akerna MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
∞ Upside
$20.00 Price Target
Short Interest
Healthy
1.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.57 out of 5 stars


KERN stock logo

About Akerna Stock (NASDAQ:KERN)

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.


KERN Stock News Headlines

Akerna (NASDAQ:KERN) Stock Price Up 36.9%
Akerna Corp. Simplifies Stock Structure, Alters Fiscal Year
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Gryphon Digital Mining, Inc. Debuts on Nasdaq
Gryphon Digital Mining Debuts on Nasdaq
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Akerna Corp Ordinary Shares
Akerna Corp. Wt
Why Akerna Stock Is Exploding Higher Today
Akerna (NASDAQ: KERN)
Akerna to Sell its Cannabis Software Business
See More Headlines
Receive KERN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akerna and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2021
Today
2/29/2024
Next Earnings (Estimated)
3/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Nondepository credit institutions
Sub-Industry
N/A
Current Symbol
NASDAQ:KERN
Fax
N/A
Employees
112
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.00
High Stock Price Target
$20.00
Low Stock Price Target
$20.00
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-79,060,000.00
Net Margins
-339.99%
Pretax Margin
-208.10%

Debt

Sales & Book Value

Annual Sales
$13.65 million
Book Value
($1.52) per share

Miscellaneous

Free Float
10,228,000
Market Cap
$3.25 million
Optionable
No Data
Beta
3.02
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Ms. Jessica Billingsley (Age 47)
    Founder, CEO & Chairman of the Board
    Comp: $462.3k
  • Mr. Larry Dean Ditto Jr. (Age 57)
    Chief Financial Officer
    Comp: $177.71k
  • Mr. David R. McCullough (Age 47)
    Chief Technology Officer
    Comp: $240.43k
  • Georgia Jablon
    Communications Manager














KERN Stock Analysis - Frequently Asked Questions

Should I buy or sell Akerna stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akerna in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" KERN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KERN, but not buy additional shares or sell existing shares.
View KERN analyst ratings
or view top-rated stocks.

What is Akerna's stock price target for 2024?

1 Wall Street research analysts have issued twelve-month price objectives for Akerna's shares. Their KERN share price targets range from $20.00 to $20.00. On average, they predict the company's share price to reach $20.00 in the next year.
View analysts price targets for KERN
or view top-rated stocks among Wall Street analysts.

When is Akerna's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024.
View our KERN earnings forecast
.

How were Akerna's earnings last quarter?

Akerna Corp. (NASDAQ:KERN) announced its earnings results on Sunday, November, 7th. The company reported ($2.80) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.00) by $0.20. The firm had revenue of $5.14 million for the quarter, compared to analysts' expectations of $5.11 million. During the same period in the previous year, the firm posted ($6.80) EPS.

What ETF holds Akerna's stock ?

Amplify Seymour Cannabis ETF holds 13,319 shares of KERN stock, representing 0.03% of its portfolio.

When did Akerna's stock split?

Akerna's stock reverse split on Friday, February 9th 2024. The 1-20 reverse split was announced on Friday, February 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 9th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Akerna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akerna investors own include KushCo (KSHB), Organigram (OGI), Supreme Cannabis (SPRWF), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Medical Marijuana (MJNA), MariMed (MRMD), Matinas BioPharma (MTNB), CNBX Pharmaceuticals (CNBX) and DHT (DHT).

Who are Akerna's major shareholders?

Akerna's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Akerna?

Shares of KERN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KERN) was last updated on 2/29/2024 by MarketBeat.com Staff